Notice of Results

RNS Number : 2561V

Hutchison China Meditech Limited

08 July 2009

 



Hutchison China MediTech Limited ('Chi-Med')

(AIM: HCM)

Notice of Announcement of 2009 Interim Results

London: Wednesday, 8 July 2009: Chi-Med will be announcing its interim results for the six months ended 30 June 2009 on Thursday, 30 July 2009.

Ends

Enquiries

Chi-Med   Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson   Anthony Carlisle   David Dible	Telephone: [phone] [phone] [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients. 

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

NORFGGGNMNKGLZM